###begin article-title 0
An antiinflammatory role for IKKbeta through the inhibition of "classical" macrophage activation
###end article-title 0
###begin p 1
###xml 30 51 30 51 <email xmlns:xlink="http://www.w3.org/1999/xlink">t.lawrence@qmul.ac.uk</email>
CORRESPONDENCE Toby Lawrence: t.lawrence@qmul.ac.uk
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 256 259 237 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lox</italic>
###xml 371 392 <span type="species:ncbi:1319">group B streptococcus</span>
The nuclear factor kappaB (NF-kappaB) pathway plays a central role in inflammation and immunity. In response to proinflammatory cytokines and pathogen-associated molecular patterns, NF-kappaB activation is controlled by IkappaB kinase (IKK)beta. Using Cre/lox-mediated gene targeting of IKKbeta, we have uncovered a tissue-specific role for IKKbeta during infection with group B streptococcus. Although deletion of IKKbeta in airway epithelial cells had the predicted effect of inhibiting inflammation and reducing innate immunity, deletion of IKKbeta in the myeloid lineage unexpectedly conferred resistance to infection that was associated with increased expression of interleukin (IL)-12, inducible nitric oxide synthase (NOS2), and major histocompatibility complex (MHC) class II by macrophages. We also describe a previously unknown role for IKKbeta in the inhibition of signal transducer and activator of transcription (Stat)1 signaling in macrophages, which is critical for IL-12, NOS2, and MHC class II expression. These studies suggest that IKKbeta inhibits the "classically" activated or M1 macrophage phenotype during infection through negative cross talk with the Stat1 pathway. This may represent a mechanism to prevent the over-exuberant activation of macrophages during infection and contribute to the resolution of inflammation. This establishes a new role for IKKbeta in the regulation of macrophage activation with important implications in chronic inflammatory disease, infection, and cancer.
###end p 3
###begin p 4
C.H.Y. Fong and M. Bebien contributed equally to this work.
###end p 4
###begin p 5
###xml 195 196 191 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 393 394 378 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 505 506 486 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 508 509 489 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
NF-kappaB is a ubiquitous transcription factor that regulates expression of proinflammatory and antiapoptotic genes and is thought to play an important role in driving the inflammatory response (1). NF-kappaB activation in response to proinflammatory stimuli is regulated by IkappaB kinase (IKK)beta, which has recently become a major target for the development of new antiinflammatory drugs (2). However, we have previously established both pro- and antiinflammatory roles for NF-kappaB in inflammation (3, 4). In this study, we have tested the hypothesis that NF-kappaB has tissue-specific roles in inflammation; although NF-kappaB activation in epithelial cells is required to drive the inflammatory response, NF-kappaB activity in macrophages has an opposing role in the resolution of inflammation.
###end p 5
###begin p 6
###xml 115 116 115 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 118 119 118 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 269 270 269 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
Macrophages are an extremely heterogeneous lineage displaying a range of both pro- and antiinflammatory functions (5, 6). Two extremes in the spectrum of macrophage function are represented by the "classically" activated (or M1) and the alternative (or M2) phenotypes (7). The M1 phenotype is typified by IFN-gamma-primed macrophages and is characterized by increased MHC class II, IL-12, and inducible nitric oxide synthase (NOS2) expression. M2 macrophages are characterized by decreased expression of NOS2, MHC class II, and IL-12, but elevated expression of antiinflammatory cytokines such as IL-10. The M2 phenotype is promoted by Th2 cytokines such as IL-4 and IL-13. Generally, M2 macrophages are considered antiinflammatory cells, whereas M1 macrophages are proinflammatory. The signaling pathways that regulate these phenotypes in vivo are not well understood.
###end p 6
###begin p 7
###xml 12 15 12 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lox</italic>
###xml 93 94 90 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 96 98 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
We used Cre/lox-mediated gene targeting of IKKbeta in lung epithelial cells and macrophages (9, 10) and show that IKKbeta deletion in airway epithelial cells inhibits inflammation and prevents clearance of bacteria in the lung. However, IKKbeta deletion in macrophages has the opposite role, increasing the inflammatory response and enhancing the clearance of bacteria. In addition, we show that IKKbeta activation suppresses the classically activated or M1 macrophage phenotype, and we present evidence for negative regulation of Stat1 activation by IKKbeta. These findings represent important new information regarding the role of NF-kappaB in macrophage biology during inflammation and infection. Furthermore, cross talk between IKKbeta and Stat1 signaling pathways could have implications for the development and clinical use of IKKbeta inhibitors.
###end p 7
###begin title 8
RESULTS AND DISCUSSION
###end title 8
###begin p 9
###xml 100 107 97 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ikk&#946;</italic>
###xml 123 126 117 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lox</italic>
###xml 408 411 399 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f/f</sup>
###xml 401 411 395 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ikk&#946;<sup>f/f</sup></italic>
###xml 457 464 448 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ikk&#946;</italic>
###xml 499 506 487 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ikk&#946;</italic>
###xml 548 549 533 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 551 553 536 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 601 609 583 587 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 640 648 615 619 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Epi</sup>
###xml 770 772 741 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 775 783 746 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 802 810 770 774 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Epi</sup>
###xml 955 963 919 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 972 984 933 945 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f/f-Otet-cre</sup>
###xml 996 1004 954 958 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Epi</sup>
###xml 1071 1079 1022 1026 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Epi</sup>
###xml 1190 1198 1137 1145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 1221 1229 1165 1169 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 1274 1282 1214 1222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 1291 1294 1228 1231 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f/f</sup>
###xml 1306 1314 1240 1244 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 1372 1380 1299 1303 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 1433 1448 1356 1371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, D and E</xref>
###xml 1557 1565 1477 1481 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 1643 1651 1559 1567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 D</xref>
###xml 369 384 <span type="species:ncbi:10090">transgenic mice</span>
###xml 412 416 <span type="species:ncbi:10090">mice</span>
###xml 521 525 <span type="species:ncbi:10090">mice</span>
###xml 671 675 <span type="species:ncbi:10090">mice</span>
###xml 694 715 <span type="species:ncbi:1319">group B streptococcus</span>
###xml 717 720 <span type="species:ncbi:1319">GBS</span>
###xml 811 815 <span type="species:ncbi:10090">mice</span>
###xml 850 853 <span type="species:ncbi:1319">GBS</span>
###xml 1080 1084 <span type="species:ncbi:10090">mice</span>
###xml 1099 1102 <span type="species:ncbi:1319">GBS</span>
###xml 1230 1234 <span type="species:ncbi:10090">mice</span>
###xml 1381 1385 <span type="species:ncbi:10090">mice</span>
###xml 1480 1483 <span type="species:ncbi:1319">GBS</span>
###xml 1501 1505 <span type="species:ncbi:10090">mice</span>
###xml 1566 1570 <span type="species:ncbi:10090">mice</span>
To investigate the tissue-specific role of IKKbeta in innate immunity, we specifically targeted the Ikkbeta gene using Cre/lox-mediated recombination in lung epithelial cells and myeloid cells using the clara cell-specific protein promoter (Cc10) and lysozyme promoter to express Cre in bronchial airway epithelial cells and the myeloid cell lineage, respectively. Cre transgenic mice were crossed to Ikkbetaf/f mice to generate tissue-specific deletion of Ikkbeta. Tissue-specific targeting of the Ikkbeta gene in these mice has been established (9, 10). To study innate immunity, we infected IKKbetaDeltaMye (myeloid deletion) and IKKbetaDeltaEpi (epithelial deletion) mice intranasally with group B streptococcus (GBS) and measured bacterial clearance from the lung (11). Fig. 1 A shows that IKKbetaDeltaEpi mice had impaired ability to clear the GBS infection, demonstrating significantly higher bacterial titres in the lung than littermate controls (Fig. 1 A; IKKbetaf/f-Otet-cre vs. IKKbetaDeltaEpi; *, P = 0.0242). Histological analysis of lung tissue from IKKbetaDeltaEpi mice infected with GBS revealed reduced neutrophil (PMN) recruitment and persistence of bacteria in the lung (Fig. 1 B). In contrast, IKKbetaDeltaMye mice showed enhanced clearance of bacteria (Fig. 1 C; IKKbetaf/f vs. IKKbetaDeltaMye; *, P = 0.0304), and analysis of lung tissue from IKKbetaDeltaMye mice revealed increased PMN infiltration after 4 h (Fig. 1, D and E). Furthermore, inflammation in GBS-infected control mice completely resolved after 24 h; however, in IKKbetaDeltaMye mice inflammation failed to resolve despite increased clearance of bacteria (Fig. 1 D). These experiments suggested that IKKbeta played a tissue-specific role in response to infection and that IKKbeta activity in airway epithelium was required for leukocyte recruitment and clearance of bacteria; however, IKKbeta activation in resident macrophages or myeloid cells recruited to the lung inhibited the inflammatory response and therefore impaired clearance of bacteria.
###end p 9
###begin p 10
###xml 0 60 0 57 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Tissue-specific role for IKK&#946; in Streptococcal pneumonia.</bold>
###xml 72 80 66 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Epi</sup>
###xml 92 104 79 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f/f-Otet-cre</sup>
###xml 156 157 143 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 295 296 282 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 456 464 440 444 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Epi</sup>
###xml 578 586 555 559 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Epi</sup>
###xml 640 641 613 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 672 680 641 645 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 692 695 654 657 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f/f</sup>
###xml 778 779 740 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 957 960 916 919 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f/f</sup>
###xml 1021 1029 977 981 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 1114 1122 1062 1066 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 1134 1137 1075 1078 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f/f</sup>
###xml 1271 1272 1210 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
###xml 163 166 <span type="species:ncbi:1319">GBS</span>
###xml 380 383 <span type="species:ncbi:1319">GBS</span>
###xml 393 397 <span type="species:ncbi:10090">mice</span>
###xml 465 469 <span type="species:ncbi:10090">mice</span>
###xml 704 708 <span type="species:ncbi:10090">mice</span>
###xml 851 854 <span type="species:ncbi:1319">GBS</span>
###xml 864 868 <span type="species:ncbi:10090">mice</span>
###xml 961 965 <span type="species:ncbi:10090">mice</span>
###xml 1030 1034 <span type="species:ncbi:10090">mice</span>
###xml 1138 1142 <span type="species:ncbi:10090">mice</span>
###xml 1157 1160 <span type="species:ncbi:1319">GBS</span>
Tissue-specific role for IKKbeta in Streptococcal pneumonia. (A) IKKbetaDeltaEpi and IKKbetaf/f-Otet-cre control mice were infected intranasally with 5 x 106 CFUs GBS in PBS. Bronchialveolar lavage was performed after 4 h, and CFUs were determined by serial dilution on Todd-Hewitt agar plates (n = 11-14; *, P = 0.0242). (B) Hematoxylin and eosin stain (left, H+E) of lungs from GBS-infected mice after 4 h showed reduced leukocyte infiltration in IKKbetaDeltaEpi mice (arrows). Gram stain (right) of infected lungs showed accumulation of bacteria in alveolar spaces of IKKbetaDeltaEpi lungs (arrows). Representative panels are shown from n = 8. Bar, 100 mum. (C) IKKbetaDeltaMye and IKKbetaf/f control mice were infected as described above, and BAL CFUs were measured at 4 h (n = 11-14; *, P = 0.0304). (D) Hematoxylin and eosin stain of lungs from GBS-infected mice after 4 and 24 h showed resolution of peribronchial inflammation in the lungs of IKKbetaf/f mice at 24 h (top, arrows); however, inflammation in IKKbetaDeltaMye mice fails to resolve (bottom, arrows). Bar, 200 mum. (E) PMN recruitment in IKKbetaDeltaMye and IKKbetaf/f mice infected with GBS was counted under high power field after hematoxylin and eosin stain. Data are represented as mean +/- SEM of n = 8 (**, P = 0.005).
###end p 10
###begin p 11
###xml 39 47 36 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 205 213 195 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 302 310 285 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 444 452 423 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 489 497 465 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 596 604 568 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 B</xref>
###xml 613 616 582 585 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f/f</sup>
###xml 628 636 594 598 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 807 815 769 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 917 925 872 876 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 932 940 883 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 949 952 897 900 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f/f</sup>
###xml 964 972 909 913 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 1137 1138 1068 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 1212 1220 1137 1141 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 1227 1235 1148 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 1348 1356 1266 1274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 1413 1421 1328 1332 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 1539 1547 1447 1451 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 1636 1644 1540 1548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 D</xref>
###xml 1764 1772 1665 1669 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 2010 2018 1900 1904 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 2117 2125 2003 2011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 E</xref>
###xml 2338 2346 2224 2232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 F</xref>
###xml 2396 2398 2282 2284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 2496 2497 2382 2383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 2663 2664 2549 2550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
###xml 75 78 <span type="species:ncbi:1319">GBS</span>
###xml 214 218 <span type="species:ncbi:10090">mice</span>
###xml 273 276 <span type="species:ncbi:1319">GBS</span>
###xml 311 315 <span type="species:ncbi:10090">mice</span>
###xml 342 345 <span type="species:ncbi:1319">GBS</span>
###xml 498 502 <span type="species:ncbi:10090">mice</span>
###xml 513 516 <span type="species:ncbi:1319">GBS</span>
###xml 788 791 <span type="species:ncbi:1319">GBS</span>
###xml 801 805 <span type="species:ncbi:10090">mice</span>
###xml 926 930 <span type="species:ncbi:10090">mice</span>
###xml 1192 1195 <span type="species:ncbi:1319">GBS</span>
###xml 1221 1225 <span type="species:ncbi:10090">mice</span>
###xml 1422 1426 <span type="species:ncbi:10090">mice</span>
###xml 1468 1471 <span type="species:ncbi:1319">GBS</span>
###xml 1481 1485 <span type="species:ncbi:10090">mice</span>
###xml 1548 1552 <span type="species:ncbi:10090">mice</span>
###xml 1630 1634 <span type="species:ncbi:10090">mice</span>
###xml 1773 1777 <span type="species:ncbi:10090">mice</span>
###xml 1935 1938 <span type="species:ncbi:1319">GBS</span>
###xml 1948 1952 <span type="species:ncbi:10090">mice</span>
###xml 2019 2023 <span type="species:ncbi:10090">mice</span>
###xml 2184 2187 <span type="species:ncbi:1319">GBS</span>
###xml 2197 2201 <span type="species:ncbi:10090">mice</span>
We next systemically challenged IKKbetaDeltaMye mice with a lethal dose of GBS and monitored their survival to determine if the increased inflammatory response could confer resistance to infection. IKKbetaDeltaMye mice were indeed more resistant to systemic infection with GBS. More than 60% of IKKbetaDeltaMye mice survived a lethal dose of GBS beyond 48 h, whereas >90% of littermate controls had died within 24 h, and none survived to 48 h (Fig. 2 A). Furthermore, resistance of IKKbetaDeltaMye mice to lethal GBS infection correlated with significantly lower titres of bacteria in the blood (Fig. 2 B; IKKbetaf/f vs. IKKbetaDeltaMye; **, P = 0.0057). To investigate the mechanism for this resistance, we measured the expression of proinflammatory cytokines in the spleen and serum of GBS-infected mice. Fig. 2 C shows a significant increase in the levels of protective Th1 cytokines IFN-gamma and IL-12 in IKKbetaDeltaMye mice (Fig. 2 C; IKKbetaf/f vs. IKKbetaDeltaMye; IFN-gamma: *, P = 0.0148; IL-12: **, P = 0.0023). Recently it has been reported that IKKbeta inhibits caspase 1-dependent IL-1beta release in LPS-stimulated PMNs (4); however, we found no increase in serum IL-1beta in GBS-infected IKKbetaDeltaMye mice (Fig. 2 C). In fact, IL-1beta levels were slightly decreased, although these data did not reach statistical significance (Fig. 2 C). To further analyze the macrophage phenotype in IKKbetaDeltaMye mice, we isolated peritoneal macrophages from GBS-infected mice and measured MHC class II expression by FACS. IKKbetaDeltaMye mice showed a threefold increase in MHC class II expression compared with control mice (Fig. 2 D). Expression of the costimulatory molecules CD80 (B7.1) and CD86 (B7.2) were also increased on macrophages from IKKbetaDeltaMye mice, whereas CD124 (IL-4Ralpha) expression was decreased (Fig. S1 A, available at ). We also analyzed IL-12p40 and arginase-1 mRNA expression in the spleen from GBS-infected mice; although expression of IL-12p40 was increased in IKKbetaDeltaMye mice, expression of the antiinflammatory macrophage marker arginase-1 was reciprocally decreased (Fig. 2 E). In addition, immunohistochemical analysis of lungs from GBS-infected mice revealed dramatically increased NOS2 expression in alveolar macrophages, whereas NOS2 expression in lung epithelium remained unchanged (Fig. 2 F). IL-12 is a critical cytokine for host defense (12) and, along with MHC class II and NOS2, is a marker for classically activated or M1 macrophages (7). On the other hand, increased expression of arginase-1 and IL-10 is characteristic of alternative M2 macrophage activation, which is dependent on CD124 expression (7).
###end p 11
###begin p 12
###xml 0 59 0 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink">IKK&#946; inhibits M1 macrophage activation during infection.</bold>
###xml 71 79 65 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 91 94 78 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f/f</sup>
###xml 160 161 147 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 207 208 194 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 384 385 371 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 496 497 476 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 778 779 754 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1044 1052 1017 1021 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 1185 1186 1154 1155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
###xml 167 170 <span type="species:ncbi:1319">GBS</span>
###xml 605 608 <span type="species:ncbi:1319">GBS</span>
###xml 618 622 <span type="species:ncbi:10090">mice</span>
###xml 772 776 <span type="species:ncbi:10090">mice</span>
###xml 956 959 <span type="species:ncbi:1319">GBS</span>
###xml 1053 1057 <span type="species:ncbi:10090">mice</span>
IKKbeta inhibits M1 macrophage activation during infection. (A) IKKbetaDeltaMye and IKKbetaf/f control mice were infected by intraperitoneal injection of 5 x 107 CFUs GBS in PBS, and survival was monitored (n = 16-17). (B) Blood was collected at 4 h by retroorbital bleed. Serial dilutions of blood samples were plated in triplicate on Todd-Hewitt agar plates, and CFUs were counted (n = 9-10; **, P = 0.0057). (C) Serum levels of IL-12p70, IL-1beta, and spleen IFN-gamma were measured by ELISA (n = 7-8; IL-12p70: **, P = 0.0023; IFN-gamma: *, P = 0.0148). (D) Total RNA was isolated from the spleens of GBS-infected mice for real-time PCR analysis of IL-12p40 and arginase-1 expression. Data are represented as fold induction of mRNA expression compared with uninfected mice (n = 7-8). (E) MHC class II expression on peritoneal macrophages measured by FACS (percentage of positive cells indicated). (F) Immunohistochemical analysis of NOS2 expression in GBS-infected lungs shows increased expression of NOS2 in alveolar macrophages of IKKbetaDeltaMye mice (arrows), whereas expression in bronchial epithelial cells remains unchanged (asterisks). Representative panels are shown from n = 8. Bar, 200 mum.
###end p 12
###begin p 13
###xml 241 242 234 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 244 246 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 280 288 270 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Epi</sup>
###xml 483 491 463 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 570 572 543 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 730 732 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 876 877 845 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 919 927 885 889 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 934 935 896 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 1019 1027 978 982 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 1133 1141 1085 1089 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 1208 1213 1153 1154 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;</sup>
###xml 1282 1287 1220 1221 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;</sup>
###xml 1302 1317 1236 1251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, A and B</xref>
###xml 1599 1607 1530 1534 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 1808 1809 1735 1736 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1814 1815 1741 1742 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1899 1900 1826 1827 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1905 1906 1832 1833 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1919 1920 1846 1847 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1923 1931 1850 1858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 2008 2016 1932 1936 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 2143 2151 2060 2064 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 2158 2166 2071 2079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 D</xref>
###xml 2234 2242 2144 2148 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 2313 2321 2219 2227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 F</xref>
###xml 2520 2528 2423 2427 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 2535 2543 2434 2442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 E</xref>
###xml 2552 2555 2448 2451 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f/f</sup>
###xml 2567 2575 2460 2464 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 289 293 <span type="species:ncbi:10090">mice</span>
###xml 492 496 <span type="species:ncbi:10090">mice</span>
###xml 641 644 <span type="species:ncbi:1319">GBS</span>
###xml 928 932 <span type="species:ncbi:10090">mice</span>
###xml 999 1002 <span type="species:ncbi:1319">GBS</span>
###xml 1028 1032 <span type="species:ncbi:10090">mice</span>
###xml 1142 1146 <span type="species:ncbi:10090">mice</span>
###xml 1608 1612 <span type="species:ncbi:10090">mice</span>
###xml 2017 2021 <span type="species:ncbi:10090">mice</span>
###xml 2044 2048 <span type="species:ncbi:10090">mice</span>
###xml 2152 2156 <span type="species:ncbi:10090">mice</span>
###xml 2243 2247 <span type="species:ncbi:10090">mice</span>
###xml 2413 2417 <span type="species:ncbi:10090">mice</span>
###xml 2529 2533 <span type="species:ncbi:10090">mice</span>
Previous work from our group and others has demonstrated that IKKbeta and NF-kappaB activation in bronchial epithelium is required for leukocyte recruitment and inflammation in the lung by regulating the expression of chemotactic cytokines (9, 13). The impaired ability of IKKbetaDeltaEpi mice to clear bacteria is therefore quite expected; however, the finding that IKKbeta deletion in myeloid cells increases inflammation and bacterial clearance was somewhat surprising. In IKKbetaDeltaMye mice, IKKbeta expression is effectively deleted in both macrophages and PMNs (14). PMNs are the major defense against extracellular bacteria such as GBS, although macrophage activation is also critical to PMN recruitment in inflammation (15). Previous work from our group has also shown that NF-kappaB can have a proapoptotic role in leukocytes during the resolution of inflammation (3), which was recently confirmed in IKKbetaDeltaMye mice (4); however, we found no difference in apoptosis in the lungs of GBS-infected IKKbetaDeltaMye mice (not depicted). We performed in vitro killing assays with macrophages and PMNs isolated from IKKbetaDeltaMye mice to test their direct antimicrobial activity. Although IKKbetaDelta macrophages showed some level of increased killing in vitro, IKKbetaDelta PMNs did not (Fig. 3, A and B). This suggested increased phagocytic killing by macrophages, probably through increased NOS2 expression, and macrophage-mediated PMN recruitment was responsible for enhanced clearance of bacteria rather than increased PMN activation. To test this hypothesis, we challenged IKKbetaDeltaMye mice intranasally with a noninfectious stimulus, bacterial LPS, to measure activation of alveolar macrophages and PMN recruitment. Lung tissue was collected for FACS analysis of PMN recruitment (CD11b+ Gr-1+ staining), and macrophage activation was measured by MHC class II expression (CD11b+ Gr-1- MHC class II+). Fig. 3 C shows increased MHC class II expression on alveolar macrophages from IKKbetaDeltaMye mice compared with control mice. FACS analysis of lung cells also revealed increased PMN recruitment in LPS-challenged IKKbetaDeltaMye mice (Fig. 3 D). Immunohistochemical analysis of LPS-stimulated lungs from IKKbetaDeltaMye mice also revealed increased NOS2 expression in alveolar macrophages (Fig. 3 F). In addition, cytokine analysis of bronchialveolar lavage fluid (BAL) from LPS-challenged mice showed increased IL-12 production but reduced levels of the antiinflammatory cytokine IL-10 in IKKbetaDeltaMye mice (Fig. 3 E; IKKbetaf/f vs. IKKbetaDeltaMye; IL-12: *, P = 0.0318), in keeping with an increase in M1 macrophage activation.
###end p 13
###begin p 14
###xml 0 69 0 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink">IKK&#946; inhibits M1 macrophage activation in response to LPS in vivo.</bold>
###xml 154 162 148 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 174 177 161 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f/f</sup>
###xml 245 253 229 233 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 265 268 242 245 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f/f</sup>
###xml 512 513 489 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 518 519 495 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 610 611 587 588 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 616 617 593 594 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 630 631 607 608 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 779 780 754 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 946 947 919 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1052 1060 1022 1026 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 1145 1148 1108 1111 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f/f</sup>
###xml 1209 1210 1172 1173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 178 182 <span type="species:ncbi:10090">mice</span>
###xml 216 219 <span type="species:ncbi:1319">GBS</span>
###xml 269 273 <span type="species:ncbi:10090">mice</span>
###xml 733 737 <span type="species:ncbi:10090">mice</span>
###xml 893 897 <span type="species:ncbi:10090">mice</span>
###xml 1039 1043 <span type="species:ncbi:10090">mice</span>
###xml 1061 1065 <span type="species:ncbi:10090">mice</span>
###xml 1157 1161 <span type="species:ncbi:10090">mice</span>
###xml 1215 1219 <span type="species:ncbi:10090">mice</span>
IKKbeta inhibits M1 macrophage activation in response to LPS in vivo. (A) Peritoneal macrophages (PM) and (B) neutrophils (PMN) were isolated from IKKbetaDeltaMye and IKKbetaf/f mice for in vitro killing assays with GBS (MOI of 5:1). (C) IKKbetaDeltaMye and IKKbetaf/f mice were challenged intranasally with 10 ng LPS in PBS. After 4 h, lungs were harvested and digested for FACS analysis of CD11b (myeloid), Gr-1 (PMN), and MHC class II expression. A representative histogram of MHC class II expression on CD11b+ Gr-1- alveolar macrophages is shown. (D) Tabulated data of mean fluorescence intensity for CD11b+ Gr-1- MHC class II+-activated macrophages in the lung and PMN recruitment as percentage of BAL cells from LPS-challenged mice (data are represented as mean +/- SEM of n = 6). (E) In parallel experiments, IL-12 and IL-10 levels were measured in lung homogenates from LPS-challenged mice by ELISA. Data are represented as mean +/- SEM (n = 8; *, P = 0.0381). (F) Immunohistochemical analysis of NOS2 expression in LPS-challenged mice. IKKbetaDeltaMye mice show increased expression of NOS2 in alveolar macrophages compared with IKKbetaf/f control mice (arrows). Representative panels are shown from n = 6 mice. Bar, 100 mum.
###end p 14
###begin p 15
###xml 44 49 41 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;</sup>
###xml 152 160 142 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 584 589 563 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;</sup>
###xml 654 662 629 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 902 913 870 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, B&#8211;D</xref>
###xml 1007 1009 975 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 1036 1041 1001 1002 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;</sup>
###xml 1055 1063 1016 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 1153 1155 1114 1116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 1374 1375 1328 1329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 1438 1440 1392 1394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 1636 1641 1581 1582 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;</sup>
###xml 1655 1663 1596 1604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 D</xref>
###xml 1764 1769 1699 1700 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;</sup>
###xml 1849 1857 1776 1784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 A</xref>
###xml 1866 1871 1790 1791 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;</sup>
###xml 2294 2299 2199 2200 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;</sup>
###xml 2313 2321 2214 2222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 B</xref>
###xml 2344 2349 2242 2243 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;</sup>
###xml 2589 2591 2477 2479 <sup xmlns:xlink="http://www.w3.org/1999/xlink">dn</sup>
###xml 2618 2620 2506 2508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 2623 2631 2511 2519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 C</xref>
###xml 2664 2666 2549 2551 <sup xmlns:xlink="http://www.w3.org/1999/xlink">dn</sup>
###xml 2839 2841 2721 2723 <sup xmlns:xlink="http://www.w3.org/1999/xlink">dn</sup>
###xml 2910 2918 2788 2796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 D</xref>
###xml 3287 3295 3147 3155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 E</xref>
###xml 3518 3520 3378 3380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 161 165 <span type="species:ncbi:10090">mice</span>
###xml 1580 1583 <span type="species:ncbi:1319">GBS</span>
We further analyzed the phenotype of IKKbetaDelta macrophages after stimulation in vitro. Both resident and elicited peritoneal macrophages from IKKbetaDeltaMye mice express normal levels of typical macrophage lineage markers (including CD11b, F4/80, and CD68) and display no distinctive morphology (not depicted). Peritoneal macrophages were elicited and stimulated in vitro with heat-killed bacteria over a 24-h time course, and protein extracts were prepared for biochemical analysis. As expected, there was a profound impairment in IKK activity and NF-kappaB activation in IKKbetaDelta macrophages, whereas activation of JNK MAPK remained unchanged (Fig. 4 A). However, although the absence of IKK activity was associated with decreased expression of pro-IL-1beta and TNF-alpha, expression of NOS2 was in fact elevated, which correlated with increased tyrosine phosphorylation of Stat1 (pY-Stat1) (Fig. 4, B-D). Expression of the endogenous inhibitor of Stat1, suppressor of cytokine signaling (SOCS)1 (16), was unaltered in IKKbetaDelta macrophages (Fig. 4 B). Stat1 is a critical transcription factor for NOS2, IL-12, and MHC class II expression (17). These data suggest that IKKbeta activity in macrophages suppresses NOS2 as well as MHC class II and IL-12 expression during infection by antagonizing Stat1. M1 macrophage activation is typified by IFN-gamma priming (7), and IFN signaling in macrophages absolutely requires Stat1 (17). In macrophages stimulated in vitro with Toll-like receptor ligands, Stat1 is activated by the autocrine production of IFN-beta; however, GBS-induced IFN-beta expression was inhibited in IKKbetaDelta macrophages (Fig. 4 D). To investigate a role of IKKbeta in the cross regulation of Stat1 signaling, we stimulated IKKbetaDelta macrophages with bacterial LPS and recombinant IFN-gamma in vitro. As shown in Fig. 5 A, IKKbetaDelta macrophages had increased activation of Stat1 and NOS2 expression when stimulated with LPS/IFN-gamma, whereas activation of Stat3 appeared unchanged. IFN-gamma and Stat1 strongly activate MHC class II expression in macrophages. To confirm the in vivo data described above, we measured MHC class II expression on macrophages stimulated in vitro with IFN-gamma. MHC class II expression was dramatically enhanced with IKKbetaDelta macrophages (Fig. 5 B). In addition, IKKbetaDelta macrophages showed an increased ability to drive T cell proliferation in an allogenic mixed lymphocyte assay (Fig. S1 B). In further experiments, we used a recombinant adenovirus to express a dominant-negative inhibitor of IKKbeta (IKKbetadn) in macrophages in vitro (18). Fig. 5 C shows that expression of IKKbetadn increased both Stat1 activation and NOS2 expression upon stimulation with LPS. Similar results were obtained with heat-killed bacteria (not depicted). Expression of IKKbetadn also dramatically increased LPS/IFN-gamma-induced IL-12 production (Fig. 5 D). To confirm the role of IKKbeta in the suppression of Stat1 transcriptional activity, we performed reporter assays in RAW 264.7 macrophages using a GAS luciferase reporter gene. Transient overexpression of IKKbeta in RAW cells inhibited GAS reporter activity, whereas transfection of the endogenous NF-kappaB inhibitor IkappaBalpha increased GAS reporter activation (Fig. 5 E). As a positive control, overexpression of SOCS1 inhibited GAS activity. Interestingly, previous studies have also described sustained IL-12 expression in macrophages deficient in p50 and heterozygous for RelA expression (19), suggesting that NF-kappaB activation downstream of IKKbeta suppresses IL-12 expression. However, these studies did not include analysis of Stat1 activation. Our data would suggest that IL-12 expression is inhibited in macrophages by the NF-kappaB-dependent expression of a Stat1 inhibitor other than SOCS1.
###end p 15
###begin p 16
###xml 0 63 0 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">IKK&#946; inhibits Stat-1 activation in GBS-infected macrophages.</bold>
###xml 103 111 97 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 123 126 110 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f/f</sup>
###xml 382 386 361 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1-54</sup>
###xml 398 402 377 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1-79</sup>
###xml 505 507 480 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 1058 1059 1013 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 38 41 <span type="species:ncbi:1319">GBS</span>
###xml 127 131 <span type="species:ncbi:10090">mice</span>
###xml 174 177 <span type="species:ncbi:1319">GBS</span>
IKKbeta inhibits Stat-1 activation in GBS-infected macrophages. (A) Peritoneal macrophages from IKKbetaDeltaMye and IKKbetaf/f mice were stimulated in vitro with heat-killed GBS (MOI of 20:1). Protein extracts were prepared at the indicated time points for biochemical analysis. IKK and JNK activity was measured by IP kinase assay (KA) using recombinant substrates GST-IkappaBalpha1-54 or GST-cJun1-79, respectively. NF-kappaB activation was measured by electrophoretic mobility shift assay (EMSA) using 32P-labeled kappaB consensus oligonucleotide. (B) Expression of IKK, pro-IL-1beta, NOS2, tyrosine 701 phosphorylation of Stat1 (pY-Stat1), serine 726 phosphorylation of Stat1 (pS-Stat1), total Stat1, and SOCS1 was measured by immunoblot analysis of cell lysates using actin as a loading control. (C) In parallel experiments, TNF-alpha production in cell culture supernatants was measured by ELISA, and (D) total RNA was isolated for real-time PCR analysis of TNF-alpha (Tnfa) and IFN-beta (Ifnb) mRNA expression. Data are represented as mean +/- SEM of n = 4. Representative data are shown from at least three independent experiments.
###end p 16
###begin p 17
###xml 0 52 0 45 <bold xmlns:xlink="http://www.w3.org/1999/xlink">IKK&#946; inhibits IFN-&#947; signaling in macrophages.</bold>
###xml 92 100 82 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 112 115 95 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f/f</sup>
###xml 405 413 381 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 425 428 394 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f/f</sup>
###xml 711 713 670 672 <sup xmlns:xlink="http://www.w3.org/1999/xlink">dn</sup>
###xml 900 902 856 858 <sup xmlns:xlink="http://www.w3.org/1999/xlink">dn</sup>
###xml 1068 1069 1018 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 206 211 <span type="species:ncbi:10090">mouse</span>
###xml 429 433 <span type="species:ncbi:10090">mice</span>
IKKbeta inhibits IFN-gamma signaling in macrophages. (A) Peritoneal macrophages from IKKbetaDeltaMye and IKKbetaf/f mice were stimulated in vitro with 100 ng/ml LPS in combination with 100 U/ml recombinant mouse IFN-gamma, and protein extracts were prepared at the indicated time points. NOS2 expression, pY-Stat1, and pY-Stat3 were measured by immunoblot analysis. (B) Peritoneal macrophages from IKKbetaDeltaMye and IKKbetaf/f mice were stimulated in vitro, with IFN-gamma and MHC class II expression analyzed by FACS. Representative data are shown from at least three independent experiments. (C) BMDMs were infected with recombinant adenovirus expressing a dominant-negative inhibitor of IKKbeta (Ad-IKKbetadn) or EGFP (Ad-GFP) 48 h before stimulation with LPS. NOS2 and pY-Stat1 expression was measured by immunoblot analysis at the indicated time points. (D) BMDMs were infected with Ad-IKKbetadn or Ad-GFP before stimulation with LPS/IFN-gamma, and IL-12p40 production was measured in cell culture supernatants by ELISA. Data are represented as mean +/- SEM of n = 4. (E) RAW 264.7 macrophages were transfected with GAS luciferase reporter and either empty vector (pCDNA) or cDNA expressing IKKbeta, IkappaBalpha, or SOCS1. After LPS/IFN-gamma stimulation for 6 h, GAS reporter activity was measured by dual luciferase activity assay. Data are represented as relative light units (RLU) normalized for transfection efficiency with pRLTK.
###end p 17
###begin p 18
###xml 215 217 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
We previously described a role for IKKalpha, the sister kinase of IKKbeta, in limiting inflammation during infection and resistance to septic shock, by regulating the magnitude and duration of NF-kappaB activation (13). In the current study, we describe a specific role for IKKbeta in limiting the expression of Stat-1-regulated genes. There is clearly still much to learn about the relative and specific roles for IKKalpha and IKKbeta in inflammation and immunity. Our working hypotheses, based on previously published work and data presented here, is that IKKalpha acts to limit inflammation by inhibiting the persistent expression of NF-kappaB-dependent proinflammatory genes. However, IKKbeta/NF-kappaB also acts to limit Stat-1 activity and the overexpression of Stat-1-dependent genes as a result of autocrine and paracrine IFN signaling. These antiinflammatory roles for the IKK complex have clear implications for the clinical use of IKK inhibitors.
###end p 18
###begin p 19
###xml 205 213 199 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 244 267 234 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryptococcus neoformans</italic>
###xml 362 364 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 374 382 361 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 513 516 493 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f/f</sup>
###xml 528 536 505 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 714 717 684 687 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f/f</sup>
###xml 729 737 696 700 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 817 825 777 781 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 1385 1386 1334 1335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 1388 1389 1337 1338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 214 218 <span type="species:ncbi:10090">mice</span>
###xml 244 256 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 244 267 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
###xml 269 271 <span type="species:ncbi:5207">Cn</span>
###xml 274 276 <span type="species:ncbi:5207">Cn</span>
###xml 383 387 <span type="species:ncbi:10090">mice</span>
###xml 402 404 <span type="species:ncbi:5207">Cn</span>
###xml 474 478 <span type="species:ncbi:10090">mice</span>
###xml 595 597 <span type="species:ncbi:5207">Cn</span>
###xml 607 611 <span type="species:ncbi:10090">mice</span>
###xml 826 830 <span type="species:ncbi:10090">mice</span>
###xml 1272 1274 <span type="species:ncbi:5207">Cn</span>
Here, we have described a new role for IKKbeta in the suppression of M1 macrophage activation during infection through the inhibition of Stat1 activity. To further test this hypothesis, we infected IKKbetaDeltaMye mice with the fungal pathogen Cryptococcus neoformans (Cn). Cn infects macrophages and promotes an M2 phenotype to evade a protective Th1 response (20). IKKbetaDeltaMye mice infected with Cn showed increased clearance of fungi after 10 d compared with control mice (Fig. S2 B, available at ; IKKbetaf/f vs. IKKbetaDeltaMye; *, P = 0.003). FACS analysis of BAL and lung tissue from Cn-infected mice showed MHC class II expression on alveolar macrophages was significantly increased (Fig. S2 C; IKKbetaf/f vs. IKKbetaDeltaMye; *, P = 0.0172). In addition, the proportion of T cells in the lungs of IKKbetaDeltaMye mice was elevated, although these data did not reach statistical significance (Fig. S2 C). These changes correlated with increased IFN-gamma in BAL and reduced levels of Th2 cytokines IL-4 and IL-5 (Fig. S2 D), suggesting a switch to a protective Th1 response. These data, and that described above, suggest that IKKbeta inhibits M1 macrophage activation during infection with both extracellular Streptococci and the intracellular fungal pathogen Cn. The precise pathophysiological significance of M1 and M2 macrophage populations is not yet well established (6, 7). However, it is clear that M1 macrophage activation is critical to control certain infections, but a switch to an M2 phenotype may limit the innate immune response and be required for the resolution of inflammation.
###end p 19
###begin p 20
###xml 244 245 234 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 247 249 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 380 381 366 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 383 385 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 538 542 524 528 <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="article-reference" vol="205" page="1261" id="N0x3d24180N0x4966860" xlink:href="18490490" ext-link-type="pubmed">1261</related-article>
###xml 561 563 547 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 658 659 641 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 661 663 644 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 932 940 909 913 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 941 945 <span type="species:ncbi:10090">mice</span>
In summary, IKKbeta plays a tissue-specific role in inflammation. In resident tissue cells, such as lung epithelium, IKKbeta-mediated NF-kappaB activation drives cytokine and chemokine production required to initiate the inflammatory response (9, 13). However, NF-kappaB activation in resident macrophages or leukocytes recruited during inflammation has an antiinflammatory role (3, 21). This may represent a mechanism to prevent the over-exuberant activation of macrophages during inflammation. In a parallel study in this issue on page 1261, Hagemann et al. (22) show that inhibition of IKKbeta in tumor-associated macrophages, which have an M2 phenotype (8, 23), also leads to increased Stat1 activation and a polarized M1 phenotype (increased; NOS2, MHC class II, and IL-12). However, in this context IKKbeta inhibition confers enhanced tumoricidal activity, analogous to the increased antimicrobial activity observed in IKKbetaDeltaMye mice. It will be interesting to investigate if pathogens can highjack the IKKbeta-NF-kappaB pathway to evade M1 macrophage activation and innate immunity in a similar fashion to tumor cells.
###end p 20
###begin p 21
Considering the dominant role of Stat1 in regulation of NOS2, MHC class II, and IL-12 expression, it is likely that activation of this pathway is a major determinant of the M1 macrophage phenotype. Collectively, these data suggest that IKKbeta activation plays an important role in suppression of this phenotype, contributing to both the resolution of inflammation during infection and the suppression of macrophage tumoricidal activity in cancer. The potential to manipulate the inflammatory phenotype of macrophages by targeting IKKbeta may offer therapeutic opportunities for the treatment of inflammatory diseases, infection, and cancer.
###end p 21
###begin title 22
MATERIALS AND METHODS
###end title 22
###begin title 23
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice.
###end title 23
###begin p 24
###xml 46 49 43 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f/f</sup>
###xml 58 66 52 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 75 87 62 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f/f-Otet-cre</sup>
###xml 100 108 84 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Epi</sup>
###xml 134 135 114 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 137 139 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 149 152 126 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f/f</sup>
###xml 248 260 222 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f/f-LysM-cre</sup>
###xml 269 277 240 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Mye</sup>
###xml 296 308 260 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f/f-Otet-cre</sup>
###xml 366 388 327 349 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f/f-Otet-cre-CC10-rtta</sup>
###xml 397 405 355 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Epi</sup>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 172 176 <span type="species:ncbi:10090">mice</span>
###xml 279 283 <span type="species:ncbi:10090">mice</span>
###xml 407 411 <span type="species:ncbi:10090">mice</span>
The generation and characterization of IKKbetaf/f, IKKbetaDeltaMye, IKKbetaf/f-Otet-cre, and IKKbetaDeltaEpi mice has been described (9, 10). IKKbetaf/f littermate control mice on a C57Bl6/J genetic background were used for experiments with IKKbetaf/f-LysM-cre (IKKbetaDeltaMye) mice, and IKKbetaf/f-Otet-cre littermate controls were used in experiments with IKKbetaf/f-Otet-cre-CC10-rtta (IKKbetaDeltaEpi) mice. Animal husbandry and procedures were performed in accordance with Queen Mary University of London UK Home Office guidelines.
###end p 24
###begin title 25
Infections.
###end title 25
###begin p 26
###xml 129 132 123 126 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600</sub>
###xml 157 158 151 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8</sup>
###xml 280 281 274 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 307 309 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 762 763 755 756 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 1304 1305 1290 1291 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 13 16 <span type="species:ncbi:1319">GBS</span>
###xml 235 239 <span type="species:ncbi:10090">Mice</span>
###xml 312 314 <span type="species:ncbi:5207">Cn</span>
###xml 721 725 <span type="species:ncbi:10090">Mice</span>
###xml 769 771 <span type="species:ncbi:5207">Cn</span>
###xml 787 791 <span type="species:ncbi:10090">Mice</span>
###xml 1243 1247 <span type="species:ncbi:10090">mice</span>
The clinical GBS isolate, NCTC10/84 (serotype V), was grown in Todd-Hewitt Broth (Difco) without agitation at 37degreesC to an OD600 of 0.4, equivalent to 108 CFUs/ml. Bacteria collected by centrifugation were washed with sterile PBS. Mice were inoculated intranasally with 3 x 107 CFUs NCTC in 30 mul PBS (11). Cn strain 52 was obtained from the American Type Culture Collection and grown to stationary phase (48-72 h) at room temperature in Sabouraud dextrose broth (Difco). The cultures were washed in saline, counted on a hemocytometer, and diluted in sterile PBS. Stock concentrations and viability were confirmed by plating on Sabouraud agar plates and incubation for 48 h at room temperature before colony counts. Mice were inoculated intranasally with 105 CFUs Cn in 30 mul PBS. Mice were killed when indicated, and their tracheas were cannulated for BAL with 3 aliquots of 0.8 ml ice-cold PBS. Serial dilutions of BAL fluid were plated in triplicate, and CFUs were determined. Lung tissue was removed and digested at 37degreesC in collagenase solution, and single cell suspensions were prepared for FACS analysis. In parallel experiments, lung tissue was collected for histological and biochemical analysis. For survival experiments, mice were inoculated by intraperitoneal injection with 5 x 107 CFUs NCTC in 0.3 ml PBS, as described above. Lung, liver, and spleen were collected postmortem for histological and biochemical analysis.
###end p 26
###begin title 27
LPS lung inflammation.
###end title 27
###begin p 28
###xml 51 67 50 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 51 67 <span type="species:ncbi:562">Escherichia coli</span>
Mice were challenged intranasally with 10 mug LPS (Escherichia coli serotype B5:055; Sigma-Aldrich) in PBS. BAL fluid was collected as described above. Lung tissue was removed and digested at 37degreesC in collagenase solution, and single cell suspensions were prepared for FACS analysis. In parallel experiments, lung tissue was collected for histological and biochemical analysis.
###end p 28
###begin title 29
Macrophage and PMN isolation and stimulation.
###end title 29
###begin p 30
###xml 80 82 80 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 831 833 831 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 835 837 835 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 1085 1090 <span type="species:ncbi:10090">mouse</span>
Bone marrow-derived macrophages (BMDMs) were generated as described previously (11). Peritoneal macrophages were elicited by intraperitoneal injection of 1.5 ml of 3% thioglycollate (Difco) or 1% Biogel (Bio-Rad Laboratories). After 3 d, cells were harvested and plated in RPMI 1640 supplemented with 10% heat-inactivated FCS, 100 U/ml penicillin/streptomycin, and 2 mM glutamine. Peritoneal PMNs were isolated 4 h after thioglycollate injection and maintained in RPMI 1640 supplemented with 10% heat-inactivated autologous serum, 100 U/ml penicillin/streptomycin, and 2 mM glutamine. For infection experiments, bacteria were prepared as described above, macrophages were washed with antibiotic-free media, and bacteria were added at a multiplicity of infection (MOI) of 5:1. Killing assays were performed as described previously (11, 24). In some experiments, macrophages were treated with heat-killed bacteria, and bacteria were prepared as described above and heat killed for 30 min at 80degreesC. For other experiments, LPS was used at a concentration of 100 ng/ml and recombinant mouse IFN-gamma was used at 100 U/ml (PeproTech).
###end p 30
###begin title 31
Adenovirus preparation.
###end title 31
###begin p 32
###xml 247 249 241 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink">dn</sup>
###xml 412 414 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 525 528 509 512 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f/f</sup>
###xml 616 619 597 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f/f</sup>
###xml 777 783 <span type="species:ncbi:10090">murine</span>
Recombinant, replication-deficient adenoviral vectors were developed to express cDNA in primary macrophages. Virus-encoding GFP was used to assess infection efficiency. Virus expressing a kinase-defective dominant-negative form of IKKbeta (IKKbetadn) was used to inhibit IKKbeta activity and NF-kappaB activation. These viruses are E1/E3 deleted, belong to the Ad5 serotype, and have been used in other studies (18). Approximately 80-90% of BMDMs were found to express GFP when infected with virus at an MOI of 200:1. IKKbetaf/f BMDMs were infected with recombinant adenovirus expressing Cre recombinase, and IKKbetaf/f BMDMs infected with Adv-GFP were used as a control. Infections were performed at day 4 of macrophage differentiation in the presence of 10 ng/ml recombinant murine M-CSF (PeproTech).
###end p 32
###begin title 33
Gene expression analysis and ELISA.
###end title 33
###begin p 34
Total cellular RNA was isolated using TRIzol (Invitrogen) and analyzed by RT- PCR with a SyBr Green (5700 thermocycler; PE Biosystems) or RNase protection assay (RPA). Primer sequences are available upon request. For RT-PCR analyses, all values were normalized to the level of cyclophilin mRNA. For RPA analyses, total RNA was hybridized with RNA probes using the Riboquant Multiprobe RPA System (BD Biosciences) according to the manufacturer's instructions. Cytokine levels in cell culture supernatants were determined by sandwich ELISA (R&D Systems and BD Biosciences) performed according to the manufacturer's instructions.
###end p 34
###begin title 35
Kinase assay, electrophoretic mobility shift assay, and immunoblotting.
###end title 35
###begin p 36
###xml 263 265 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 524 526 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 637 638 620 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 640 642 623 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
Whole cell lysates were prepared, and IKK or JNK kinase activity was measured after immunoprecipitation with anti-IKKgamma or anti-JNK1 antibody (BD Biosciences) using recombinant GST-IkappaBalpha (1-54) or GST-cJun (1-29), respectively, as described previously (11). IKK and JNK recovery was determined by immunoblotting with anti-IKKalpha (BD Biosciences) or anti-JNK antibody (Santa Cruz Biotechnology, Inc.). Immunoblotting was performed on SDS-PAGE gel-separated whole cell lysates or nuclear and cytoplasmic extracts (11). Electrophoretic mobility shift assays were performed with 2 mug of protein extract as described previously (3, 11).
###end p 36
###begin title 37
Flow cytometry.
###end title 37
###begin p 38
###xml 197 198 197 198 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
###xml 44 49 <span type="species:ncbi:10090">mouse</span>
Murine Fc receptors were blocked using anti-mouse CD16/CD32 Fc Block (BD Biosciences). For staining, cells were washed and resuspended in PBS supplemented with 1% heat-inactivated FBS and 0.01% NaN3. Antibodies were diluted in this buffer and used at a final concentration of between 2 and 20 mug/ml. The following antibodies were used: MHC class II (Ia)-PE, CD11b-APC, CD86-PE, CD80-PE, CD124 (IL-4Ralpha)-PE, and CD4-FITC (BD Biosciences). Incubations with antibodies were performed for 30 min on ice. Labeled cells were analyzed by flow cytometry on a FACScan flow cytometer and analyzed using CellQuest software (Becton Dickinson).
###end p 38
###begin title 39
Mixed lymphocyte reaction.
###end title 39
###begin p 40
###xml 2 3 2 3 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 122 123 122 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 228 229 227 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
###xml 188 192 <span type="species:ncbi:10090">mice</span>
103 elicited macrophages from C57Bl6/J mice were plated in 96-well plates and stimulated overnight with 100 ng/ml LPS. CD4+ T cells were negatively selected from the lymph nodes of BALB/c mice and labeled with 5 muM CSFE. 5 x 105 T cells were added to macrophages and co-cultured for 4 d. Cells were harvested, 7-AAD was added to exclude nonviable cells, and CFSE dilution in the viable cell population was measured by FACS.
###end p 40
###begin title 41
Transfections and reporter assays.
###end title 41
###begin p 42
3T3 or RAW264.7 cells were transiently transfected using FuGene HD (Roche). Cells were plated in 12-well plates and grown until 80-90% confluency. Cells were cotransfected with 500 ng of GAS reporter gene plasmid, 500 ng of an expression vector, and 10 (3T3) or 50 ng (RAW264.7) pRLTK (Promega). 22 h after transfection, cells were treated with LPS and IFN-gamma for 6 h. Cells were harvested in 75 mul Passive Lysis Buffer (Promega). Luciferase activity was determined with the Dual-Luciferase Reporter Assay System according to the manufacturer's instructions (Promega).
###end p 42
###begin title 43
Statistical analysis.
###end title 43
###begin p 44
###xml 138 139 136 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
At least three independent experiments were performed, and representative data are shown. Data are represented as mean +/- SEM. Student's t test or Mann-Whitney test was performed where appropriate to test the statistical significance between datasets and p-values indicated.
###end p 44
###begin title 45
Online supplemental material.
###end title 45
###begin p 46
###xml 65 70 62 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;</sup>
###xml 163 165 <span type="species:ncbi:5207">Cn</span>
Fig. S1 shows the increased immunostimulatory activity of IKKbetaDelta macrophages. Fig. S2 shows that macrophage IKKbeta activity inhibits protective immunity to Cn infection. Figs. S1 and S2 are available at .
###end p 46
###begin title 47
Supplementary Material
###end title 47
###begin title 48
[Supplemental Material Index]
###end title 48
###begin p 49
This work was supported by funding from the Wellcome Trust and Medical Research Council to T. Lawrence.
###end p 49
###begin p 50
The authors have no conflicting financial interests.
###end p 50

